New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be...
Cell Therapeutics, Inc. (CTI) announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new ...
Yahoo! News